Your browser doesn't support javascript.
loading
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Bathini, Srilakshmi; Holtzman, Noa G; Koka, Rima; Singh, Zeba; Wilding, Emily; Zou, Ying; Ruehle, Kathleen; Kocoglu, Mehmet H; Badros, Ashraf; Hardy, Nancy; Yared, Jean; Rapoport, Aaron P; Fontaine, Magali; Emadi, Ashkan; El Chaer, Firas; Dahiya, Saurabh.
Affiliation
  • Bathini S; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Holtzman NG; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Singh Z; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Wilding E; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Zou Y; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Ruehle K; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Kocoglu MH; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Badros A; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Hardy N; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Yared J; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Rapoport AP; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Fontaine M; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Emadi A; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • El Chaer F; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Dahiya S; Department of Medicine, Department of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
Am J Hematol ; 94(8): E216-E219, 2019 08.
Article in En | MEDLINE | ID: mdl-31120638
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Red-Cell Aplasia, Pure / Hematopoietic Stem Cell Transplantation / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Red-Cell Aplasia, Pure / Hematopoietic Stem Cell Transplantation / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2019 Document type: Article Country of publication: United States